Summary
Silymarine-N-methylglucamine-salt has a pronounced high antioxidative function against microsomal lipid peroxidation, associated with liver injury by CCl4.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Literatur
H. M. Rauen, H. Schriewer, U. Tegtbauer undJ. E. Lasana, Arzneimittel-Forsch. (Drug Res.)23, 145 (1973).
H. M. Rauen andH. Schriewer, Arzneimittel-Forsch. (Drug Res.)21, 1194 (1971).
H. M. Rauen undH. Schriewer, Arzneimittel-Forsch. (Drug Res.)23, 148 (1973).
H. M. Rauen, H. Schriewer undH. Fels, Arzneimittel-Forsch. (Drug Res.)23, 142 (1973).
H. M. Rauen, H. Schriewer undH. Fels, Arzneimittel-Forsch. (Drug Res.)23, 143 (1973).
K. S. Rao undR. O. Recknagel, Expl. molec. Path.9, 271 (1968);10, 219 (1969).
K. S. Rao, E. A. Glende undR. O. Recknagel, Expl. molec. Path.12, 324 (1970).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rauen, H.M., Schriewer, H., Tegtbauer, U. et al. Silymarin verhindert die Lipidperoxidation bei der CCl4-Leberschädigung. Experientia 29, 1372 (1973). https://doi.org/10.1007/BF01922826
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01922826